Share
Fujifilm Corporation eyes Africa's healthcare sector
Japanese photography and imaging multinational, Fujifilm Corporation is eyeing Africa's healthcare sector with digital mammography and X-rays for detection of cancer. The firm's President and COO, Kenji Sukeno spoke to CNBC Africa's Charles Gitonga on why Fujifilm is so keen on investing in Africa's healthcare market.
Wed, 31 Aug 2016 10:11:40 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- The company's transition from a photography business to a diversified healthcare solutions provider in Africa.
- The development of advanced medical technologies, such as digital mammography systems and influenza detectors, to address critical healthcare needs on the continent.
- Fujifilm's collaborative approach with government officials and stakeholders in Africa to understand and cater to the unique healthcare challenges faced by different countries.
Japanese multinational, Fujifilm Corporation, historically associated with photography and imaging, is making significant strides in Africa's healthcare sector. The firm's President and COO, Kenji Sukeno, in an exclusive interview with CNBC Africa's Charles Gitonga, highlighted the company's commitment to investing in healthcare solutions across the continent. Fujifilm's journey in Africa dates back to 1970 when it began distributing products in the region. Over the years, the company has established a strong presence with key offices in Dubai, South Africa, and Morocco. While photography remains a core business for Fujifilm, the company has diversified into medical care, printing, and industrial materials, with a particular focus on healthcare. Sukeno emphasized the importance of addressing the high mortality rates associated with diseases like breast cancer in Africa. To combat this pressing issue, Fujifilm has developed advanced digital mammography systems that facilitate early detection and diagnosis of cancer. The company believes in not just selling products but also in providing extensive training and education to healthcare professionals to ensure effective utilization of their solutions.Fujifilm's dedication to healthcare extends beyond cancer detection. In response to health crises like the Ebola outbreak in West Africa, the company collaborated with France to produce a medication called Fabi Pilabil, which proved instrumental in treating affected individuals. Additionally, Fujifilm has introduced cutting-edge influenza detectors with applications in virus detection, including the Ebola virus. The firm's proactive approach and innovative solutions have garnered attention in Japan and are set to make a significant impact in the African healthcare landscape.Looking ahead, Fujifilm is poised to further expand its investments in Africa's healthcare sector. The company's future plans include continued focus on eradicating diseases like breast cancer through early detection methods, as well as leveraging their expertise in medical technology to address emerging healthcare challenges. By actively engaging with government officials and stakeholders across Africa, Fujifilm aims to understand the unique healthcare needs of each country and collaboratively work towards providing sustainable solutions. The company's participation in conferences like TCCAT6 serves as a platform to not only showcase their offerings but also to gather crucial insights into the healthcare challenges faced by African nations. Through strategic partnerships and a deep commitment to improving healthcare outcomes, Fujifilm is poised to make a lasting impact on the healthcare landscape in Africa.
SIGN UP FOR OUR NEWSLETTER
DAILY UPDATE
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.